Bernard A. Fox

Chairman, President & Chief Executive Officer at UbiVac LLC

Bernard A. Fox

Bernard A. Fox

Chairman, President & Chief Executive Officer at UbiVac LLC

Biography

Founder of UbiVac LLC, Bernard A. Fox is Chairman, President & Chief Executive Officer at this company. Dr. Fox is also Laboratory Chief at Earle Chiles Research Institute and Vice President of International Society for Biological Therapy of Cancer.

Overview
Career Highlights

UbiVac LLC

RelSci Relationships

101

Number of Boards

6

Relationships
RelSci Relationships are individuals Bernard A. Fox likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Kapoor-Pharma Investments LP

Relationship likelihood: Strong

Founder at Third Age Pharma LLC

Relationship likelihood: Strong

Partner at Southport Marina Development Co. LLC

Relationship likelihood: Strong

Chief Financial Officer at JVM Capital LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at New Haven Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Director, President & Chief Executive Officer at INSYS Therapeutics, Inc.

Relationship likelihood: Strong

Fund Advisor at EJF Capital LLC

Relationship likelihood: Strong

Former Chief Executive Officer & Executive Vice President at Rhone-Poulenc Rorer, Inc.

Relationship likelihood: Strong

Secretary at EJ Financial Enterprises, Inc.

Relationship likelihood: Strong

Founder at Definiens AG

Relationship likelihood: Strong

Paths to Bernard A. Fox
Potential Connections via
Relationship Science
You
Bernard A. Fox
Chairman, President & Chief Executive Officer at UbiVac LLC
Career History
Chairman, President & Chief Executive Officer
2005 - Current

UbiVac LLC engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases. The company was founded by Bernard A. Fox and Hong-Ming Hu in 2005 and is headquartered in Portland, OR.

Laboratory Chief
1994 - Current
Vice President
Current

International Society for Biological Therapy of Cancer is an American nonprofit company located in Milwaukee, WI, that operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives.

Boards & Committees
Director
2004 - 2011

NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL.

Director
2004 - 2011

InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ.

Director
2004 - 2010

INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.

Political Donations
$250
2008

Former President of United States

$500
2004

DNC Service Corp. operates a political party. It is an organization which raises fund for the Democratic Party which has been a part of the U.S. political landscape. The company plans the presidential nominating convention, promotes candidates from the local to the national level and sets the party platform. DNC Service was founded in 1848 and is located in Washington, DC.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bernard A. Fox. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bernard A. Fox's profile does not indicate a business or promotional relationship of any kind between RelSci and Bernard A. Fox.